A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance ...
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
For the first time, University of Hawaiʻi at Mānoa researchers have studied how work, volunteering and leisure activities ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
STAFFORD, Texas - Greenwich LifeSciences, Inc. (NASDAQ:GLSI), a clinical-stage biopharmaceutical company valued at $163 million, has announced the commencement of analysis on the open label HLA data ...
Greenwich LifeSciences (GLSI) announced an update on FLAMINGO-01 open label HLA data. Analysis of the open label data from FLAMINGO-01 has ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果